August 18, 2020
UNITED STATES OF AMERICA v. TEVA PHARMACEUTICALS USA, INC. et al
Case Number:
1:20-cv-11548
Court:
Nature of Suit:
Other Statutes: False Claims Act
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 14, 2023
Teva Scores FCA Trial Delay, Kickback Law Appeal At 1st Circ.
Teva Pharmaceuticals won a major reprieve Monday when a Massachusetts federal judge delayed an impending False Claims Act trial threatening $10 billion in liability and permitted the drugmaker to pursue First Circuit review of a hotly contested FCA issue that has opened a clear circuit split.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login